Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

Anemia occurs when there aren’t enough red blood cells in the body. Many types of anemia exist, and each type may have different causes. For example, heart disease could cause anemia, or it could ...

Treating anemia in patients with CKD earlier, before hemoglobin levels fall below 9.0 g/dL, may reduce risks for cardiovascular events. Delaying renal anemia treatment with long-acting ...

Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine ("InSilico"), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal ...

GREENVILLE, S.C. (WSPA)—31 million Americans live with anemia, according to the Centers for Disease Control, but what is it?

Dr. Shah was compensated by BMS for his participation. Photo Credit: Shutterstock As you age, feeling tired or short of breath may be dismissed as a part of getting older, but it’s important to talk ...

The development of new or worsening anemia did not decrease Jakafi’s efficacy in treating primary or secondary myelofibrosis. Patients with primary or secondary myelofibrosis who developed new or ...

Company will host investor conference call and webcast tomorrow, December 24 at 8:00 a.m. ET CAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (AGIO), a commercial-stage ...

In normochromic anemia, which is a type of blood disorder, red blood cells have typical concentrations of hemoglobin and are typical in color. It may result from underlying conditions, and treatment ...

Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...

U.S. Erythropoietin Drugs Market size was USD 4.02 Billion in 2025 and is expected to reach USD 6.18 Billion by 2035 owing to the strong dialysis infrastructure and increasing anemia treatment demand.